Πλοήγηση ανά Συγγραφέα "Wurth, P."
-
Endothelin-1 plasma levels in hemodialysis treatment - The influence of type 2 diabetes
Liakopoulos, V.; Wurth, P.; Mertens, P. R.; Eleftheriadis, T.; Kourti, P.; Voliotis, G.; Heintz, B.; Koukoulis, G. N.; Stefanidis, I. (2005)In patients on chronic hemodialysis the prevalence of atherosclerosis is increased and is by far the leading cause of morbidity and mortality. Endothelin-1, an endothelium-derived peptide with vasoconstrictive and mitogenic ... -
Plasma endothelin-1 in hemodialysis treatment - the influence of hypertension
Stefanidis, I.; Wurth, P.; Mertens, P. R.; Ikonomov, V.; Philippidis, G.; Golphinopoulos, S.; Makropoulos, V.; Liakopoulos, V.; Mann, H.; Heintz, B. (2004)In patients on chronic hemodialysis hypotensive episodes are frequently encountered during the course of treatment and the prevalence of atherosclerosis is increased. Endothelin-1 (ET-1), an endothelium-derived peptide ...